BioMarin Pharmaceutical (BMRN, $82.17) was a top weekly loser, falling to $82.17 per share. Of the 913 stocks analyzed in the Biotechnology Industry throughout the week of April 4/18/2024 - 4/25/2024, 2024, of them (4) exhibited an Uptrend while of them (5) were in a Downtrend.